Genpharmasec Limited (BOM:531592)

Genpharmasec Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	188.32	19.93	16.07	35.34	25.78
Short-Term Investments	-	16.84	9.54	24.51	76.69	22.84
Trading Asset Securities	-	12.6	7.09	18.83	31.19	-
Cash & Short-Term Investments	38.2	217.76	36.56	59.41	143.21	48.63
Cash Growth	-16.31%	495.68%	-38.47%	-58.52%	194.49%	-27.21%
Accounts Receivable	-	91	57.09	64.48	75.25	70.33
Other Receivables	-	0.49	0.08	2.64	-	-
Receivables	-	91.56	61.98	73.92	75.25	70.33
Inventory	-	75.82	89.77	80.21	45.62	34.6
Prepaid Expenses	-	-	0.21	0.16	0.01	0.04
Other Current Assets	-	24.6	0.77	1.75	3.72	5.25
Total Current Assets	-	409.74	189.29	215.44	267.81	158.84
Property, Plant & Equipment	-	8.39	1	1.04	0.48	0.48
Long-Term Investments	-	176.4	-	-	1.38	34.76
Long-Term Deferred Tax Assets	-	4.26	8.46	0.03	0.03	0.04
Other Long-Term Assets	-	-	-	-	0.13	-
Total Assets	-	711.26	198.75	216.5	278.2	247.57
Accounts Payable	-	23.79	13.7	62.21	71.16	55.41
Accrued Expenses	-	1.76	0.21	0.11	0.4	0.35
Short-Term Debt	-	-	6.01	-	-	-
Current Income Taxes Payable	-	-	-	-	0.03	1.46
Other Current Liabilities	-	1.47	0.72	0.49	-	-
Total Current Liabilities	-	27.02	20.64	62.81	71.58	57.23
Long-Term Debt	-	32.1	24.81	-	-	-
Long-Term Leases	-	6.78	-	-	-	-
Other Long-Term Liabilities	-	-	-	0	-	-
Total Liabilities	-	65.91	45.45	62.81	71.58	57.23
Common Stock	-	553.72	276.86	276.86	276.86	216.86
Additional Paid-In Capital	-	207.65	-	-	-	-
Retained Earnings	-	-46.82	-45.66	-48.69	13.05	0.48
Comprehensive Income & Other	-	-70.59	-77.89	-74.47	-83.3	-26.99
Total Common Equity	653.99	643.95	153.3	153.7	206.62	190.35
Minority Interest	-	1.4	-	-	-	-
Shareholders' Equity	655.11	645.35	153.3	153.7	206.62	190.35
Total Liabilities & Equity	-	711.26	198.75	216.5	278.2	247.57
Total Debt	48.94	38.89	30.82	-	-	-
Net Cash (Debt)	-10.74	178.87	5.74	59.41	143.21	48.63
Net Cash Growth	-	3018.39%	-90.34%	-58.52%	194.49%	-27.21%
Net Cash Per Share	-0.02	0.58	0.02	0.21	0.53	0.10
Filing Date Shares Outstanding	604	533.72	276.86	276.86	276.86	216.86
Total Common Shares Outstanding	604	533.72	276.86	276.86	276.86	216.86
Working Capital	-	382.72	168.66	152.63	196.23	101.62
Book Value Per Share	1.27	1.21	0.55	0.56	0.75	0.88
Tangible Book Value	653.99	643.95	153.3	153.7	206.62	190.35
Tangible Book Value Per Share	1.27	1.21	0.55	0.56	0.75	0.88
Buildings	-	0.69	0.69	0.69	0.22	0.19
Machinery	-	1.02	0.84	0.68	0.46	0.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.